In the evolving landscape of US visa adjudication, health-related grounds of inadmissibility are drawing closer scrutiny. Immigrants with underlying health conditions may face increased risk of visa denial, particularly if their conditions pose a public health risk or could result in excessive demand on US health resources. This development has direct implications for China-based corporate executives and investors applying for L-1, EB-1C, and EB-5 visas.
For L-1 and EB-1C applicants—typically senior executives or managers transferring to US affiliates—this means the standard I-693 medical examination (required by INA §212(a)(1)(A)(ii)) must be meticulously completed and submitted. Incomplete or outdated medical reports often lead to RFEs (Requests for Evidence) or visa interview delays. Last quarter, we handled a case involving a fintech executive whose diabetes was not fully documented, resulting in a two-month delay at consular processing. We advised the client to obtain a detailed endocrinologist report and proof of medication adherence, which was accepted without further issue.
Given these developments, we suggest two concrete steps for our clients:
- 1Schedule the USCIS-approved Form I-693 medical examination early, ideally before filing adjustment applications or visa petitions, to avoid processing delays. Confirm the examining physician’s familiarity with USCIS requirements, including vaccination standards and documentation format.
- 1Prepare a comprehensive medical summary from treating physicians detailing diagnosis, treatment history, medication compliance, and prognosis. This is especially critical for applicants with chronic or complex conditions. Such documentation should be submitted proactively with visa applications or provided promptly upon RFE to prevent prolonged adjudication.
In summary, the increasing attention to health conditions in visa adjudication presents both challenges and opportunities. Clients who act early to secure complete, USCIS-compliant medical documentation will reduce risks of delay or denial. This is particularly important for executives transferring under L-1 or EB-1C and investors pursuing EB-5 green cards, where timing and documentation completeness are critical. We encourage clients to review their medical status now, arrange for updated evaluations, and consult us for tailored strategies.
What does this mean for you? If you are preparing an L-1, EB-1C, or EB-5 application, do not wait until the last minute to complete your medical exam and gather supporting documentation. Early action will save time, reduce stress, and increase your chances of a smooth visa process.
